Opthea Ltd (CKDXF) stock
CKDXFOTCBiological Products, (No Diagnostic Substances)Fiscal year ends June 30Also trades as CYVNY
$0.01+0.00 (0.00%)
Close on Oct 19, 2026Market cap –P/E –Yield –
Opthea total assets
Total assets on the balance sheet at the end of each period.
Opthea's total assets was $56.80M at Jun 30, 2025. For fiscal 2025 it was $56.80M, down 69.9% from the year before. The highest annual figure on record is $188.79M in fiscal 2024.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $56.80M | -69.9% |
| FY2024 | Jun 30, 2024 | $188.79M | +91.4% |
| FY2023 | Jun 30, 2023 | $98.64M | +64.3% |
| FY2022 | Jun 30, 2022 | $60.05M | -56.6% |
| FY2021 | Jun 30, 2021 | $138.41M | +180.0% |
| FY2020 | Jun 30, 2020 | $49.44M | +86.9% |
| FY2019 | Jun 30, 2019 | $26.45M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | $56.80M | -48.0% |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | $188.79M | +36.4% |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $98.64M | +99.5% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | $60.05M | +127.1% |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | $109.22M | – |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $138.41M | – |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $49.44M | – |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | $26.45M | – |
See a number that looks wrong?